Researchers say how quickly a person’s pupil dilates while taking cognitive tests
Alzheimer’s disease (AD) begins to alter and damage the brain years — even decades — before symptoms appear, making early identification of AD risk paramount to slowing its progression.
In a new study published online in the September 9, 2019 issue of the Neurobiology of Aging, scientists at University of California San Diego School of Medicine say that, with further developments, measuring how quickly a person’s pupil dilates while they are taking cognitive tests may be a low-cost, low-invasive method to aid in screening individuals at increased genetic risk for AD before cognitive decline begins.
In recent years, researchers investigating the pathology of AD have primarily directed their attention at two causative or contributory factors: the accumulation of protein plaques in the brain called amyloid-beta and tangles of a protein called tau. Both have been linked to damaging and killing neurons, resulting in progressive cognitive dysfunction.
The new study focuses on pupillary responses which are driven by the locus coeruleus (LC), a cluster of neurons in the brainstem involved in regulating arousal and also modulating cognitive function. Tau is the earliest occurring known biomarker for AD; it first appears in the LC; and it is more strongly associated with cognition than amyloid-beta. The study was led by first author William S. Kremen, PhD, and senior author Carol E. Franz, PhD, both professors of psychiatry and co-directors of the Center for Behavior Genetics of Aging at UC San Diego School of Medicine.
The LC drives pupillary response — the changing diameter of the eyes’ pupils — during cognitive tasks. (Pupils get bigger the more difficult the brain task.) In previously published work, the researchers had reported that adults with mild cognitive impairment, often a precursor to AD, displayed greater pupil dilation and cognitive effort than cognitively normal individuals, even if both groups produced equivalent results. Critically, in the latest paper, the scientists link pupillary dilation responses with identified AD risk genes.
“Given the evidence linking pupillary responses, LC and tau and the association between pupillary response and AD polygenic risk scores (an aggregate accounting of factors to determine an individual’s inherited AD risk), these results are proof-of-concept that measuring pupillary response during cognitive tasks could be another screening tool to detect Alzheimer’s before symptom appear,” said Kremen.
Learn more: How the Eyes Might Be Windows to the Risk of Alzheimer’s Disease
The Latest on: Diagnosing Alzheimer’s
[google_news title=”” keyword=”diagnosing Alzheimers” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Diagnosing Alzheimer’s
- Alzheimer's All-Star Basketball Classic's founder, Gordon Thomas, inspired by dad's battle with diseaseon April 26, 2024 at 11:50 am
Celeste Taylor, Lester Quinones and Diego Maldonado are just a few of the talented players who have participated in the competitions.
- How TikTok is shaping caregiving narratives for Alzheimer’s, dementiaon April 25, 2024 at 12:00 pm
Thousands of caregivers have built large followings on TikTok, showing how they support family members living with dementia or Alzheimer’s.
- High Level of Fat-Transporting Molecule Linked to Alzheimer'son April 25, 2024 at 8:02 am
A new study by researchers at the University of Mississippi and Harvard University may have uncovered a risk factor for Alzheimer's disease.
- New Alzheimer’s Blood Test Gets FDA Designation, Maker Seeks to Play ‘Important Role’ in Diagnosison April 24, 2024 at 5:24 pm
A new blood test that could help identify Alzheimer’s earlier from healthcare company Roche has received a Breakthrough Device Designation from the U.S.
- The Long Goodbye: coming to terms with a loved one's Alzheimer's diagnosison April 24, 2024 at 4:01 pm
After her mother was diagnosed with Alzheimer's in 2010, Keri Kitay began an almost 10-year journey with the disease, as a carer, and a daughter watching her mum slip further away every day. In this ...
- Rubama: As legendary coach Norbie Wilson battles Alzheimer’s, First Colonial, Cape Henry will play in his honoron April 24, 2024 at 12:13 pm
Cape Henry and First Colonial, two of the top baseball teams in Hampton Roads, will come together on Saturday to honor former Patriots coach Norbie Wilson and raise money for Alzheimer’s.
- The number of people with Alzheimer’s disease in their 40s or 50s could be underestimatedon April 24, 2024 at 8:33 am
Could you develop this disease at such an early age? Your family history could be telling, medical professionals say.
- Biogen stock climbs on strong Alzheimer’s drug saleson April 24, 2024 at 4:56 am
Biogen on Wednesday reported a first-quarter profit that exceeded estimates as the Cambridge drug maker cut costs and sales of its closely watched Alzheimer’s drug, Leqembi, surpassed ...
- Alzheimer's drug adoption in US slowed by doctors' skepticismon April 23, 2024 at 10:26 am
Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among ...
- Those with thyroid issues shouldn't jump to self-diagnosis of Alzheimer'son April 22, 2024 at 3:31 am
These symptoms often lead to the individual thinking that he/she might have the onset of Alzheimer's or dementia. The individual shouldn't rush to judgment about that possibility. Rather, the symptoms ...
via Bing News